174 related articles for article (PubMed ID: 21492260)
1. Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein C primes the immune system and decreases pneumococcal nasopharyngeal colonization in mice.
Hernani Mde L; Ferreira PC; Ferreira DM; Miyaji EN; Ho PL; Oliveira ML
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):263-72. PubMed ID: 21492260
[TBL] [Abstract][Full Text] [Related]
2. Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge.
Campos IB; Darrieux M; Ferreira DM; Miyaji EN; Silva DA; Arêas AP; Aires KA; Leite LC; Ho PL; Oliveira ML
Microbes Infect; 2008 Apr; 10(5):481-8. PubMed ID: 18403234
[TBL] [Abstract][Full Text] [Related]
3. Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice.
Ferreira DM; Darrieux M; Silva DA; Leite LC; Ferreira JM; Ho PL; Miyaji EN; Oliveira ML
Clin Vaccine Immunol; 2009 May; 16(5):636-45. PubMed ID: 19279169
[TBL] [Abstract][Full Text] [Related]
4. Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei.
Vintiñi EO; Medina MS
BMC Immunol; 2011 Aug; 12():46. PubMed ID: 21834957
[TBL] [Abstract][Full Text] [Related]
5. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.
Oliveira ML; Arêas AP; Campos IB; Monedero V; Perez-Martínez G; Miyaji EN; Leite LC; Aires KA; Lee Ho P
Microbes Infect; 2006 Apr; 8(4):1016-24. PubMed ID: 16549380
[TBL] [Abstract][Full Text] [Related]
6. Negligible role for pneumococcal surface protein A (PspA) and pneumococcal surface protein C (PspC) in the nasopharyngeal colonization of mice with a serotype 6B pneumococcal strain.
Araujo AP; Oliveira MLS; Miyaji EN
Microb Pathog; 2023 Dec; 185():106391. PubMed ID: 37839762
[TBL] [Abstract][Full Text] [Related]
7. Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae.
Shah P; Briles DE; King J; Hale Y; Swiatlo E
Exp Biol Med (Maywood); 2009 Apr; 234(4):403-9. PubMed ID: 19176871
[TBL] [Abstract][Full Text] [Related]
8. Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice.
Pimenta FC; Miyaji EN; Arêas AP; Oliveira ML; de Andrade AL; Ho PL; Hollingshead SK; Leite LC
Infect Immun; 2006 Aug; 74(8):4939-44. PubMed ID: 16861686
[TBL] [Abstract][Full Text] [Related]
9. Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A).
Ferreira DM; Oliveira ML; Moreno AT; Ho PL; Briles DE; Miyaji EN
Microb Pathog; 2010 Jun; 48(6):205-13. PubMed ID: 20206678
[TBL] [Abstract][Full Text] [Related]
10. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae.
Balachandran P; Brooks-Walter A; Virolainen-Julkunen A; Hollingshead SK; Briles DE
Infect Immun; 2002 May; 70(5):2526-34. PubMed ID: 11953392
[TBL] [Abstract][Full Text] [Related]
11. Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection.
Laiño J; Villena J; Suvorov A; Zelaya H; Ortiz Moyano R; Salva S; Alvarez S
PLoS One; 2018; 13(11):e0206661. PubMed ID: 30395582
[TBL] [Abstract][Full Text] [Related]
12. Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization.
Greene CJ; Marks LR; Hu JC; Reddinger R; Mandell L; Roche-Hakansson H; King-Lyons ND; Connell TD; Hakansson AP
Infect Immun; 2016 Jun; 84(6):1693-1703. PubMed ID: 27001538
[TBL] [Abstract][Full Text] [Related]
13. Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.
Tostes RO; Rodrigues TC; da Silva JB; Schanoski AS; Oliveira ML; Miyaji EN
PLoS One; 2017; 12(1):e0170157. PubMed ID: 28103277
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
Bitsaktsis C; Iglesias BV; Li Y; Colino J; Snapper CM; Hollingshead SK; Pham G; Gosselin DR; Gosselin EJ
Infect Immun; 2012 Mar; 80(3):1166-80. PubMed ID: 22158740
[TBL] [Abstract][Full Text] [Related]
15. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
Xu J; Dai W; Wang Z; Chen B; Li Z; Fan X
Clin Vaccine Immunol; 2011 Jan; 18(1):75-81. PubMed ID: 21047997
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous immunization with pneumococcal surface protein A in mice.
Nagano H; Kawabata M; Sugita G; Tsuruhara A; Ohori J; Jimura T; Miyashita K; Kurono Y; Tomonaga K; Briles DE; Fujihashi K
Laryngoscope; 2018 Mar; 128(3):E91-E96. PubMed ID: 29226330
[TBL] [Abstract][Full Text] [Related]
17. Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.
Kong IG; Sato A; Yuki Y; Nochi T; Takahashi H; Sawada S; Mejima M; Kurokawa S; Okada K; Sato S; Briles DE; Kunisawa J; Inoue Y; Yamamoto M; Akiyoshi K; Kiyono H
Infect Immun; 2013 May; 81(5):1625-34. PubMed ID: 23460513
[TBL] [Abstract][Full Text] [Related]
18. Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge.
Zhang Y; Masi AW; Barniak V; Mountzouros K; Hostetter MK; Green BA
Infect Immun; 2001 Jun; 69(6):3827-36. PubMed ID: 11349048
[TBL] [Abstract][Full Text] [Related]
19. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
[TBL] [Abstract][Full Text] [Related]
20. The factor H-binding fragment of PspC as a vaccine antigen for the induction of protective humoral immunity against experimental pneumococcal sepsis.
Ricci S; Janulczyk R; Gerlini A; Braione V; Colomba L; Iannelli F; Chiavolini D; Oggioni MR; Björck L; Pozzi G
Vaccine; 2011 Oct; 29(46):8241-9. PubMed ID: 21911026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]